Abstract
Melanoma differentiation associated gene-7 (mda-7)/interleukin-24 (IL-24), a member of the IL-10 cytokine gene family, preferentially induces cell death in neoplastic epithelial cells types while sparing their normal counterparts. The effects of mda-7/IL-24 in acute myeloid leukemia (AML) cells have not been extensively characterized. Treatment with recombinant GST-MDA-7/IL-24 potently induced apoptosis in diverse myeloid leukemia cell types including U937, HL60, MV4-11, EOL-1, and MLL/ENL cells. MDA-7/IL-24 also markedly induced apoptosis in and suppressed the colony-forming capacity of primary AML blasts but exerted minimal toxicity toward normal CD34+ hematopoietic progenitor cells. MDA-7/IL-24 lethality was associated with pronounced endoplasmic reticulum (ER) stress induction in leukemia cell lines and primary AML blasts, manifested by the accumulation of growth arrest and DNA damage-inducible protein 34 (GADD34), 78-kDa glucose-regulated protein (GRP78)/BiP, inositol-requiring enzyme 1α (IRE1α), and eukaryotic initiation factor 2α phosphorylation. It is noteworthy that short hairpin RNA (shRNA) knockdown of IRE1α, GADD34, or GRP78/BiP significantly enhanced MDA-7/IL-24-mediated apoptosis, indicating a protective role for these molecules against MDA-7/IL-24 lethality. MDA-7/IL-24 also down-regulated the antiapoptotic protein Mcl-1 and sharply increased expression of the proapoptotic proteins Bim and Noxa. Ectopic Mcl-1 expression or shRNA knockdown of Bim or Noxa significantly attenuated MDA-7/IL-24-mediated leukemia cell death. Finally, knockdown of Bax or Bak significantly reduced MDA-7/IL-24 lethality. Together, these findings indicate that MDA-7/IL-24 potently induces apoptosis in human myeloid leukemia cells through a process regulated by ER stress induction, Mcl-1 down-regulation, and Bim and Noxa up-regulation. They also suggest that MDA-7/IL-24 warrants further investigation in myeloid leukemia.
Footnotes
This work was supported by the National Institutes of Health National Cancer Institute [Grants P01-CA104177, R01-CA93738-05]; and awards from the V Foundation and the Leukemia and Lymphoma Society of America. D.S. is a Harrison Scholar and P.B.F. holds the Thelma Newmeyer Chair in Cancer Research.
Article, publication date, and citation information can be found at http://molpharm.aspetjournals.org.
doi:10.1124/mol.110.068007.
-
ABBREVIATIONS:
- MDA-7/IL-24
- melanoma differentiation associated gene-7/interleukin-24
- GST
- glutathione transferase
- L-CFU
- leukemic colony-forming units
- GADD
- growth arrest and DNA damage-inducible protein
- IRE1α
- inositol-requiring enzyme 1α
- eIF2α
- eukaryotic initiation factor 2α
- PARP
- poly(ADP-ribose) polymerase
- UPR
- unfolded protein response
- MLL-ENL
- eleven-nineteen-leukemia
- GRP78
- 78-kDa glucose-regulated protein
- AML
- acute myeloid leukemia
- ER
- endoplasmic reticulum
- shRNA
- short hairpin RNA
- AIF
- apoptosis-inducing factor
- CFU-GM
- myeloid colony-forming units
- GFP
- green fluorescent protein
- PI
- propidium iodide
- FAB
- French-American-British classification.
- Received August 5, 2010.
- Accepted September 21, 2010.
- Copyright © 2010 The American Society for Pharmacology and Experimental Therapeutics
MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|